In the current study, we sought to discover a small molecule that might be employed to treat skeletal muscle atrophy. The approach that we took was impartial and essentially distinctive from classic drug discovery procedures because it relied on systemic consequences of small molecules rather then predefined molecular targets or pathways. Curiously

Article Under Review